Cancer patients deserve to receive aggressive treatment for comorbid depression. Dr. David Spiegel and his team of researchers at Stanford University found that patients with depression may exhibit faster rates of cancer progression. The team found that depression was as dangerous a risk factor for mortality in cancer as it is in cardiovascular disease.
Join us at the Intercontinental in Berlin for the 7th Biennial Congress of The International Society of Affective Disorders, 28th – 30th April, 2014.
A home-based intervention that incorporated components of mindfulness and cognitive-behavioral therapy led to the prevention of depression, a reduction in seizures, and increased life satisfaction, a randomized study of patients with epilepsy demonstrated. “Reports are that 32%-48% of people with epilepsy experience depression,” Nancy J. Thompson, Ph.D., said at the annual meeting of the American […]
Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor antidepressants did not increase seizure frequency in a retrospective series of epilepsy patients seen at Rush University Medical Center in Chicago.
In case you missed the big news, last weekend, the American Psychiatric Association’s Board of Trustees voted on and approved the final diagnostic criteria for the fifth edition of the Diagnostic and Statistical Manual, or DSM-5, paving the way for publication next year.
Over the last decade, attention in the medical literature has gathered logarithmically to focus on potentially efficacious treatments for perinatal depression. Studies of relevant databases, editorials, and various reviews have addressed the reproductive safety concerns of antidepressant treatments, particularly selective serotonin reuptake inhibitors (SSRIs) on one hand, and the impact of untreated maternal psychiatric illness […]
Depression in patients with episodic migraine is an independent risk factor for transformation of their headache pattern into far more burdensome chronic migraine, according to data from the landmark American Migraine Prevalence and Prevention study. “The study indicates that we need to look for depression in patients with episodic migraine or chronic migraine. We need […]
Depression does more than strike at the heart; it can compromise survival for patients with metastatic kidney cancer. Researchers from the University of Texas M.D. Anderson Cancer Center in Houston found that patients with higher levels of cortisol – a stress hormone linked with depression – died significantly sooner than those with lower cortisol levels […]
Ninety minutes of aerobic exercise per week reduced depressive symptoms in patients with stable coronary heart disease to the same extent as did sertraline therapy, in a study of 101 patients published online Aug. 1 in the Journal of the American College of Cardiology. In addition, the subgroup of 44 CHD patients who met the […]
Estrogen exposure across the lifespan appears to be associated with risk of depression during the menopausal transition, according to findings from the Study of Women’s Health Across the Nation, or SWAN. Specifically, a longer total duration of estradiol exposure was found to be protective against depression during the menopausal transition, Dr. Claudio N. Soares reported […]
A sustained-release formulation of the investigational drug levomilnacipran was found superior to placebo for improving depressive symptoms in adults with major depressive disorder. The randomized, double-blind phase III trial included more than 700 patients. Treatment also was associated with significant and clinically meaningful improvements in functional health and well-being, the investigators reported.
Recurrent depression from midlife through late life increases the risk of vascular dementia, suggesting a progressive etiologic association with vascular disease, a large, long-term retrospective cohort study has shown. When depression begins only in late life, it might be part of the Alzheimer’s disease prodrome, the researchers found. Whether treatment of depression could help prevent […]
Adults with major depression were significantly less likely to discontinue treatment when they received telephone-administered cognitive behavioral therapy, compared with patients who received face-to-face CBT. However, at 6-months, those who received in-person therapy were comparatively less depressed, according to the findings of a randomized, controlled trial. The results were published June 6 in JAMA.
Current heavy smokers have a more than threefold increased risk for major depression, compared to former heavy smokers. And while the link between smoking and depression is well documented, the finding adds another twist to the debate between so-called “shared-vulnerability” and causal hypotheses about smoking and depression.
Women with depression engage in fewer healthy dieting behaviors such as eating fruits and vegetables, and more unhealthy dieting behaviors such as skipping meals, than do women who are not depressed.
The first generic formulation of the selective serotonin reuptake inhibitor escitalopram has been approved by the Food and Drug Administration, the agency announced on March 14.